Tropomyosins are a family of actin-binding proteins that play crucial roles in regulating the dynamics of actin filaments and thereby influencing various cellular processes such as cell motility, cytoskeletal organization, and muscle contraction. Among the members of this family, Tropomyosin β, Tropomyosin γ, and Tropomyosin 4 are particularly noteworthy. Tropomyosin β and Tropomyosin γ are isoforms of the tropomyosin protein encoded by different genes, while Tropomyosin 4 represents another distinct isoform. These isoforms exhibit tissue-specific expression patterns and play distinct roles in cellular functions. Tropomyosin β is primarily found in muscle tissues and is involved in regulating muscle contraction by modulating the interaction between actin and myosin filaments. Tropomyosin γ, on the other hand, is ubiquitously expressed and contributes to the regulation of cytoskeletal dynamics and cellular morphology. Tropomyosin 4, similar to other isoforms, is involved in stabilizing actin filaments and modulating cytoskeletal architecture, particularly in non-muscle cells.
Activation of tropomyosins involves complex regulatory mechanisms that influence their interactions with actin filaments and other binding partners. One of the key mechanisms of activation involves post-translational modifications such as phosphorylation, acetylation, and methylation, which can modulate the conformation and binding properties of tropomyosins. Phosphorylation, in particular, has been shown to regulate the function of tropomyosins in muscle contraction and cytoskeletal dynamics by altering their affinity for actin filaments and modulating their interactions with other regulatory proteins. Additionally, tropomyosin isoforms may undergo alternative splicing, leading to the generation of distinct variants with differential activities and binding affinities. Moreover, the activity of tropomyosins can be modulated by various signaling pathways, including those mediated by calcium ions and small GTPases, which regulate their association with actin filaments and other regulatory proteins. Overall, the activation of tropomyosins is a tightly regulated process that integrates multiple signaling inputs to orchestrate cellular functions associated with cytoskeletal dynamics and muscle contraction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can phosphorylate various substrates involved in actin filament dynamics, potentially enhancing the stability and function of tropomyosins in the cytoskeleton. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation of proteins in the actin cytoskeleton, which might enhance the function of tropomyosins. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can modulate various signaling pathways involved in cell survival and cytoskeletal organization, potentially enhancing the role of tropomyosins in stabilizing actin filaments. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels. Elevated cAMP can activate PKA, which may phosphorylate proteins associated with actin dynamics, indirectly influencing tropomyosin function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation within the cell, which could enhance tropomyosin function in actin stabilization. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments, potentially enhancing the role of tropomyosins in maintaining cytoskeletal integrity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride can activate the Wnt/β-catenin signaling pathway, which is involved in cytoskeletal dynamics, potentially influencing tropomyosin function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor. Inhibition of p38 MAPK can alter cellular stress responses, potentially influencing tropomyosin's role in the actin cytoskeleton. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), which can influence actin dynamics and potentially enhance tropomyosin function. | ||||||